ARCHIVES

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

This article is from The Cancer Letter archive.

Vol. 09 No. 21 | May 27, 1983

Download PDF Visit The Full Archive

Related Articles

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003

Coalition Of Cooperative Groups Lists High Priority Trials In Breast Cancer.

October 17, 2008

FDA Forms Office of Combination Products;

January 10, 2003

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012